← Zurück zu den InvestorenTyp VC-Fonds Sitz Basel, Basel-Stadt, Schweiz Portfolio 17 Beteiligungen, davon 8 Exits Fokus-Phasen SeedSeries ASeries B
B
BioMedPartners
VC-Fonds·Basel, Basel-Stadt
Überblick
Portfolio
- I
ImmunOs Therapeutics
Zürich
- T
TOLREMO therapeutics
- A
Alentis Therapeutics
Basel-Stadt
- N
Noema Pharma
Basel-Stadt
- A
Anaveon
Basel-Stadt
- B
Bright Peak Therapeutics
Basel-Stadt
- N
NXI Therapeutics
Basel-Stadt
- N
Numab Therapeutics
- A
Aleva Neurotherapeutics
- AExit
AMAL Therapeutics
Genf
- SExit
Sequana Medical
Zürich
- PExit
Polyphor
- VExit
VectivBio
Basel-Stadt
- MExit
Monte Rosa Therapeutics
Basel-Stadt
- EExit
ESBATech
- HExit
Hookipa Pharma
AT
- AExit
AnaptysBio
US